STOCK TITAN
  1. Home
  2. Sec-filings
  3. CC
  4. [Form 4] Chemours Co Insider Trading Activity

Director at Chemours (NYSE: CC) receives 7,182 stock units award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Chemours director Alister Cowan reported a grant of 7,182 stock units of Chemours common stock. The units were acquired at a stated price of $0.00 per share as a compensation award. Following this grant, Cowan directly holds 43,881.0397 shares or stock units in total.

The granted stock units, including deferred stock units and dividend equivalent units, will convert one-for-one into Chemours common stock when Cowan separates from service on the Board.

Positive

  • None.

Negative

  • None.
Insider Cowan Alister
Role null
Type Security Shares Price Value
Grant/Award Common Stock 7,182 $0.00 --
Holdings After Transaction: Common Stock — 43,881.04 shares (Direct, null)
Footnotes (1)
  1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. Includes deferred stock units and dividend equivalent units.
Stock units granted 7,182 units Grant of Chemours common stock units to director Alister Cowan
Grant price $0.00 per share Compensation-related award, not open-market purchase
Holdings after grant 43,881.0397 shares/units Total directly held by Alister Cowan following the transaction
Conversion ratio 1 unit = 1 share Stock units convert one-for-one to Chemours common stock
stock units financial
"Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board."
Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.
deferred stock units financial
"Includes deferred stock units and dividend equivalent units."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
dividend equivalent units financial
"Includes deferred stock units and dividend equivalent units."
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
separation from service financial
"convert one-for-one to Chemours common stock upon separation from service on the Board."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cowan Alister
(Last)(First)(Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET
(Street)
WILMINGTON DELAWARE 19899
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026A7,182(1)A$043,881.0397(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
2. Includes deferred stock units and dividend equivalent units.
/s/ Eric Stein, Attorney-in-Fact05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Chemours (CC) director Alister Cowan report in this Form 4 filing?

Alister Cowan reported receiving a grant of 7,182 Chemours stock units as a compensation award. The units were recorded at a price of $0.00 per share and increase his directly held total to 43,881.0397 shares or stock units.

Are Alister Cowan’s 7,182 Chemours stock units an open-market purchase?

No, the 7,182 Chemours stock units are a grant or award, not an open-market purchase. The transaction code "A" and a price of $0.00 per share indicate a compensation-related acquisition rather than Cowan buying shares in the market.

How many Chemours shares or units does Alister Cowan hold after this transaction?

After the grant, Alister Cowan directly holds 43,881.0397 Chemours shares or stock units. This total reflects his position following the 7,182-unit award reported in the Form 4, combining previously held amounts with the newly granted stock units.

When will Alister Cowan’s Chemours stock units convert into common stock?

The stock units will convert one-for-one into Chemours common stock when Alister Cowan separates from service on the Board. Until that separation event, they remain as stock units, including deferred stock units and dividend equivalent units credited to his account.

What do deferred stock units and dividend equivalent units mean for Chemours director awards?

Deferred stock units are promises to deliver Chemours shares in the future, typically tied to board service. Dividend equivalent units credit additional stock units corresponding to dividends that would have been paid, increasing the director’s future share count upon conversion to common stock.